Investigational Drug Information for Trehalose-6-Phosphate
✉ Email this page to a colleague
What is the drug development status for Trehalose-6-Phosphate?
Trehalose-6-Phosphate is an investigational drug.
There have been 15 clinical trials for Trehalose-6-Phosphate.
The most recent clinical trial was a Phase 2 trial, which was initiated on May 1st 2022.
The most common disease conditions in clinical trials are Alzheimer Disease, Macular Edema, and Non-alcoholic Fatty Liver Disease. The leading clinical trial sponsors are Seelos Therapeutics, Inc., Bioblast Pharma Ltd., and Mashhad University of Medical Sciences.
There are fifteen US patents protecting this investigational drug and eighty-seven international patents.
Summary for Trehalose-6-Phosphate
| US Patents | 15 |
| International Patents | 87 |
| US Patent Applications | 30 |
| WIPO Patent Applications | 24 |
| Japanese Patent Applications | 8 |
| Clinical Trial Progress | Phase 2 (2022-05-01) |
| Vendors | 6 |
Recent Clinical Trials for Trehalose-6-Phosphate
| Title | Sponsor | Phase |
|---|---|---|
| SLS-005 (Trehalose Injection) in the Treatment of Alzheimer's Disease | Seelos Therapeutics, Inc. | Phase 2 |
| SLS-005 (Trehalose Injection) in the Treatment of Alzheimer's Disease | Neuroscience Trials Australia | Phase 2 |
| Efficacy of Oral Administration of Trehalose in Patients With Parkinson Disease | Neuromed IRCCS | Phase 4 |
Clinical Trial Summary for Trehalose-6-Phosphate
Top disease conditions for Trehalose-6-Phosphate
Top clinical trial sponsors for Trehalose-6-Phosphate
US Patents for Trehalose-6-Phosphate
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Trehalose-6-Phosphate | See Plans and Pricing | Modified gram positive bacteria and uses thereof | INTREXON ACTOBIOTICS NV (Zwijnaarde, BE) | See Plans and Pricing |
| Trehalose-6-Phosphate | See Plans and Pricing | Processes of producing fermentation products | NOVOZYMES A/S (Bagsvaerd, DK) | See Plans and Pricing |
| Trehalose-6-Phosphate | See Plans and Pricing | Modified gram positive bacteria and uses thereof | INTREXON ACTOBIOTICS NV (Zwijnaarde, BE) | See Plans and Pricing |
| Trehalose-6-Phosphate | See Plans and Pricing | Production of trehalose in plants | Mogen International NV (Leiden, NL) | See Plans and Pricing |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Trehalose-6-Phosphate
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Trehalose-6-Phosphate | Denmark | DK2758512 | 2031-09-23 | See Plans and Pricing |
| Trehalose-6-Phosphate | European Patent Office | EP2758512 | 2031-09-23 | See Plans and Pricing |
| Trehalose-6-Phosphate | Spain | ES2676707 | 2031-09-23 | See Plans and Pricing |
| Trehalose-6-Phosphate | Hungary | HUE038830 | 2031-09-23 | See Plans and Pricing |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
